BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15205377)

  • 1. Effects of medroxyprogesterone and estradiol on the recovery of spermatogenesis in irradiated rats.
    Shetty G; Weng CC; Bolden-Tiller OU; Huhtaniemi I; Handelsman DJ; Meistrich ML
    Endocrinology; 2004 Oct; 145(10):4461-9. PubMed ID: 15205377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats.
    Shetty G; Wilson G; Huhtaniemi I; Shuttlesworth GA; Reissmann T; Meistrich ML
    Endocrinology; 2000 May; 141(5):1735-45. PubMed ID: 10803584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of recovery of spermatogenesis in irradiated rats by different androgens.
    Shetty G; Wilson G; Hardy MP; Niu E; Huhtaniemi I; Meistrich ML
    Endocrinology; 2002 Sep; 143(9):3385-96. PubMed ID: 12193551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen enhances recovery from radiation-induced spermatogonial arrest in rat testes.
    Porter KL; Shetty G; Shuttlesworth GA; Weng CC; Huhtaniemi I; Pakarinen P; Meistrich ML
    J Androl; 2009; 30(4):440-51. PubMed ID: 19136390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia.
    Meistrich ML; Kangasniemi M
    J Androl; 1997; 18(1):80-7. PubMed ID: 9089071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular edema is associated with spermatogonial arrest in irradiated rats.
    Porter KL; Shetty G; Meistrich ML
    Endocrinology; 2006 Mar; 147(3):1297-305. PubMed ID: 16306082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
    Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
    Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
    Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone suppression with GnRH antagonist promotes spermatogenic recovery from transplanted spermatogonial stem cells in irradiated cynomolgus monkeys.
    Shetty G; Uthamanthil RK; Zhou W; Shao SH; Weng CC; Tailor RC; Hermann BP; Orwig KE; Meistrich ML
    Andrology; 2013 Nov; 1(6):886-98. PubMed ID: 24124124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of protection of rat spermatogenesis by hormonal pretreatment: stimulation of spermatogonial differentiation after irradiation.
    Meistrich ML; Wilson G; Kangasniemi M; Huhtaniemi I
    J Androl; 2000; 21(3):464-9. PubMed ID: 10819455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis).
    Weinbauer GF; Göckeler E; Nieschlag E
    J Clin Endocrinol Metab; 1988 Aug; 67(2):284-90. PubMed ID: 3292557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship among hormonal treatments, suppression of spermatogenesis, and testicular protection from chemotherapy-induced damage.
    Meistrich ML; Wilson G; Ye WS; Thrash C; Huhtaniemi I
    Endocrinology; 1996 Sep; 137(9):3823-31. PubMed ID: 8756553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonists and antagonists stimulate recovery of fertility in irradiated LBNF1 rats.
    Meistrich ML; Wilson G; Shuttlesworth G; Huhtaniemi I; Reissmann T
    J Androl; 2001; 22(5):809-17. PubMed ID: 11545294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone inhibits spermatogonial differentiation in juvenile spermatogonial depletion mice.
    Shetty G; Wilson G; Huhtaniemi I; Boettger-Tong H; Meistrich ML
    Endocrinology; 2001 Jul; 142(7):2789-95. PubMed ID: 11415997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both testosterone and follicle-stimulating hormone independently inhibit spermatogonial differentiation in irradiated rats.
    Shetty G; Weng CC; Meachem SJ; Bolden-Tiller OU; Zhang Z; Pakarinen P; Huhtaniemi I; Meistrich ML
    Endocrinology; 2006 Jan; 147(1):472-82. PubMed ID: 16210366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development.
    Lue Y; Hikim AP; Wang C; Im M; Leung A; Swerdloff RS
    Endocrinology; 2000 Apr; 141(4):1414-24. PubMed ID: 10746645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of recovery of spermatogenesis and Leydig cell function after cessation of gonadotropin-releasing hormone antagonist treatment in the adult rat.
    Hikim AP; Swerdloff RS
    Endocrinology; 1994 Apr; 134(4):1627-34. PubMed ID: 8137724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal and stage-specific effects of recombinant human follicle-stimulating hormone on the maintenance of spermatogenesis in gonadotropin-releasing hormone antagonist-treated rat.
    Hikim AP; Swerdloff RS
    Endocrinology; 1995 Jan; 136(1):253-61. PubMed ID: 7828538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
    Page ST; Amory JK; Anawalt BD; Irwig MS; Brockenbrough AT; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.